At 10mg weekly, the average weight loss was 21.4%, approximately 49 pounds (22 kg)
Understanding the dosing landscape helps you have better conversations with your provider
You will need a diagnosis of type 2 diabetes, hypertension, high cholesterol, cardiovascular disease, or sleep apnea to qualify
Safety profile and the dysesthesia signal No discussion of retatrutide approval would be complete without addressing safety
Preclinical studies show that activation of the GLP-1R by GLP-1 or GLP-1RAs weakens the ability of alcohol to activate the mesolimbic dopamine system, as well as reduces alcohol consumption and operant self-induction
Most active individuals take between 1,000 and 2,000 mg per day